Non ‐invasive prenatal screening for chromosomal abnormalities using circulating cell-free fetal DNA in maternal plasma: Current applications, limitations and prospects

Discussion Cell-free fetal DNA testing represents the best screening method for common aneuploidies, and should its cost decrease, its use may be more widespread. But presently, contingent screening strategies may represent a cost-effective alternative. This review provides a current overview of this relevant theme.

Source: Egyptian Journal of Medical Human Genetics - August 27, 2016 Category: Genetics & Stem Cells Source Type: research